Avanir Pharmaceuticals closes open public offering of 20,930,000 shares of common stock Avanir Pharmaceuticals, Inc.00 per share, before underwriting special discounts. J ?priligy-sverige.com .P. Morgan, Deutsche Lender BofA and Securities Merrill Lynch acted as joint book-working managers for the supplying. Piper Jaffray and JMP Securities acted as co-managers for the providing. Gross arises from the providing are $230,230,000 before deducting underwriting special discounts and estimated offering expenditures payable by Avanir. Avanir intends to utilize the net proceeds from the general public providing for general corporate reasons, such as, but are not really limited by, funding NUEDEXTA commercial actions, financing our ongoing and potential clinical trials, financing the commercial release of AVP-825, if accepted, and for administrative and general expenses.